InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation in Upcoming Investor Conferences
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and quality of life for patients who have unmet medical needs, has announced that executive management personnel will be participating in two investor conferences, both scheduled to take place in June. Company officials will be at the Craig-Hallum Virtual Institutional Investor Conference, scheduled for June 2, 2021, and will be participating in…